Case Reports
doi: 10.1002/jca.21371.
Epub 2014 Nov 21.
Carfilzomib associated thrombotic microangiopathy initially treated with therapeutic plasma exchange
Affiliations
- PMID: 25413611
- DOI: 10.1002/jca.21371
Item in Clipboard
Case Reports
Carfilzomib associated thrombotic microangiopathy initially treated with therapeutic plasma exchange
J Clin Apher.
2015 Oct.
Abstract
Drug associated thrombotic microangiopathy (TMA) is a rare event causing thrombocytopenia, microangiopathic anemia, renal failure, and neurologic abnormalities. Here, we present a case of TMA that occurred during the first cycle of treatment with carfilzomib for relapsed multiple myeloma.
Keywords: carfilzomib; multiple myeloma; plasma exchange; thrombotic microangiopathy.
© 2014 Wiley Periodicals, Inc.
Similar articles
-
Carfilzomib: A cause of drug associated thrombotic microangiopathy.Transfus Apher Sci. 2016 Jun;54(3):401-4. doi: 10.1016/j.transci.2016.03.002. Epub 2016 Mar 15. Transfus Apher Sci. 2016. PMID: 27017313
-
Renal thrombotic microangiopathy and podocytopathy associated with the use of carfilzomib in a patient with multiple myeloma.BMC Nephrol. 2014 Sep 30;15:156. doi: 10.1186/1471-2369-15-156. BMC Nephrol. 2014. PMID: 25267524 Free PMC article.
-
Microangiopathy in multiple myeloma: a case of carfilzomib-induced secondary thrombotic microangiopathy successfully treated with plasma exchange and complement inhibition.BMC Nephrol. 2023 Jun 19;24(1):179. doi: 10.1186/s12882-023-03228-9. BMC Nephrol. 2023. PMID: 37337151 Free PMC article.
-
Carfilzomib‐Induced Thrombotic Microangiopathy—Two Case Reports.Cancer Rep (Hoboken). 2024 Oct;7(10):e2163. doi: 10.1002/cnr2.2163. Cancer Rep (Hoboken). 2024. PMID: 39390755 Free PMC article. Review. Spanish.
-
A review of thrombotic microangiopathies in multiple myeloma.Leuk Res. 2019 Oct;85:106195. doi: 10.1016/j.leukres.2019.106195. Epub 2019 Jul 29. Leuk Res. 2019. PMID: 31404728 Review.
Cited by
-
Mineralocorticoid Receptor Pathway Is a Key Mediator of Carfilzomib-induced Nephrotoxicity: Preventive Role of Eplerenone.Hemasphere. 2022 Oct 18;6(11):e791. doi: 10.1097/HS9.0000000000000791. eCollection 2022 Nov. Hemasphere. 2022. PMID: 36285072 Free PMC article.
-
Acute Tubular Necrosis in a Patient With Myeloma Treated With Carfilzomib.Kidney Int Rep. 2016 Jun 23;1(2):89-92. doi: 10.1016/j.ekir.2016.06.002. eCollection 2016 Jul. Kidney Int Rep. 2016. PMID: 29142917 Free PMC article. No abstract available.
-
Thrombotic microangiopathy in untreated myeloma patients receiving carfilzomib, cyclophosphamide and dexamethasone on the CARDAMON study.Br J Haematol. 2021 May;193(4):750-760. doi: 10.1111/bjh.17377. Epub 2021 Mar 1. Br J Haematol. 2021. PMID: 33650100 Free PMC article. Clinical Trial.
-
The Authors Reply.Kidney Int. 2015 Jul;88(1):200. doi: 10.1038/ki.2015.135. Kidney Int. 2015. PMID: 26126103 No abstract available.
-
Renal and pulmonary thrombotic microangiopathy triggered by proteasome-inhibitor therapy in patient with smoldering myeloma: A renal biopsy and autopsy case report.Medicine (Baltimore). 2019 Sep;98(39):e17148. doi: 10.1097/MD.0000000000017148. Medicine (Baltimore). 2019. PMID: 31574818 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
